GO:0001586 Gi/o-coupled serotonin receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001586 describes the molecular function of serotonin receptors that couple to Gi/o proteins, leading to inhibition of adenylate cyclase and reduced cAMP.
• The 5-HT1A receptor is the prototypical Gi/o-coupled serotonin receptor, and its signaling is critical for mood regulation and antidepressant response.
• Gi/o-coupled receptors, including serotonin receptors, compete for adenylyl cyclase signaling and can reduce opioid-mediated cAMP overshoot.
• Regulation of cAMP by Gi/o-coupled receptors in brain regions such as the hippocampus is stimulus-dependent and varies with genetic background.
• Gi/o-coupled serotonin receptors can influence other Gi/o-coupled receptors, as shown by mutual interactions with muscarinic M2 receptors in atrial myocytes.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of Gi/o-coupled serotonin receptor function in disease and behavior.
Description
Gi/o-coupled serotonin receptor activity (GO:0001586) is a molecular function that combines serotonin binding with the activation of the Gi/o subunit of heterotrimeric G proteins, ultimately inhibiting adenylate cyclase and decreasing cyclic AMP (cAMP) levels. This activity is central to serotonergic neurotransmission and is implicated in a wide range of physiological processes, from mood and anxiety to cardiovascular function. The 5-HT1A receptor is the best-characterized member of this family, and its signaling has been linked to antidepressant effects and behavioral regulation. Researchers study this term to understand how serotonin modulates neuronal excitability and to develop therapeutics for psychiatric and neurological disorders. Beyond the brain, Gi/o-coupled serotonin receptors also operate in peripheral tissues, where they can interact with other Gi/o-coupled receptors to fine-tune cellular responses. The importance of this GO term extends to drug discovery, as many antipsychotic and antidepressant drugs target these receptors or their downstream pathways.
Gi/o-coupled serotonin receptor activity At A Glance
| GO ID | GO:0001586 |
|---|---|
| GO term | Gi/o-coupled serotonin receptor activity |
| Ontology | molecular_function |
| Synonym | 5-HT1 receptor activity; serotonin receptor activity, coupled via Gi/o |
| Major function | Binds serotonin and activates Gi/o proteins to inhibit adenylate cyclase and reduce cAMP |
| Primary receptors | 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT1F, and other Gi/o-coupled serotonin receptors |
| Downstream effect | Decreased cAMP levels, modulation of ion channels and neurotransmitter release |
| Tissue distribution | Central nervous system, cardiovascular system, and other peripheral tissues |
| Research relevance | Target for antidepressants, anxiolytics, and antipsychotics |
What Is GO:0001586?
According to the Gene Ontology, GO:0001586 (Gi/o-coupled serotonin receptor activity) is defined as the molecular function that combines with serotonin and transmits a signal across the membrane by activating the Gi/o subunit of an associated cytoplasmic heterotrimeric G protein complex. This activation subsequently inhibits adenylate cyclase, resulting in a decrease in cyclic AMP (cAMP) levels. In simpler terms, it is the activity of serotonin receptors that slow down cAMP production via Gi/o proteins.
Why Is Gi/o-coupled serotonin receptor activity Important in Cell Biology?
Gi/o-coupled serotonin receptor activity is a fundamental signaling mechanism that regulates mood, anxiety, and cognition, and it is the primary target of many psychiatric medications. Dysregulation of this activity has been implicated in depression, anxiety disorders, and schizophrenia, making it a critical area of biomedical research. Moreover, these receptors interact with other Gi/o-coupled receptors, influencing cellular responses to opioids and other neurotransmitters, which has implications for pain management and addiction. Understanding this GO term at the molecular level is essential for developing more effective and selective therapeutics.
• Mediates the therapeutic effects of antidepressants such as SSRIs through 5-HT1A receptor activation.
• Regulates anxiety-like behavior via Gi/o signaling in limbic circuits.
• Modulates opioid signaling and cAMP overshoot, relevant to pain and addiction.
• Influences hippocampal synaptic plasticity and memory processes.
• Plays a role in cardiovascular function through interactions with muscarinic receptors.
• Contributes to the pathophysiology of schizophrenia via heteromeric receptor complexes.
• Serves as a target for drug discovery in psychiatry and neurology.
• Enables precise control of neuronal activity using optogenetic tools like cone opsins.
• Involved in motor control and anxiety regulation through GPR88 interactions.
• Provides a model for studying Gi/o-coupled receptor competition and signaling crosstalk.
What Happens During Gi/o-coupled serotonin receptor activity?
Serotonin Binding and Receptor Activation
In simple terms: Serotonin binds to the receptor, causing it to change shape and become active.
The Gi/o-coupled serotonin receptor, such as 5-HT1A, binds serotonin at its orthosteric site, inducing a conformational change that allows the receptor to act as a guanine nucleotide exchange factor for the Gi/o protein. This activation is highly specific and is the first step in transmitting the serotonin signal across the membrane.
Gi/o Protein Activation and cAMP Inhibition
In simple terms: The activated receptor turns on a G protein that then reduces cAMP levels.
Upon activation, the receptor promotes the exchange of GDP for GTP on the Gαi/o subunit, leading to dissociation of the G protein into Gαi/o and Gβγ subunits. The GTP-bound Gαi/o subunit inhibits adenylate cyclase, decreasing the production of cAMP from ATP. This reduction in cAMP affects downstream effectors such as protein kinase A (PKA) and cyclic nucleotide-gated channels.
Downstream Signaling and Cellular Effects
In simple terms: Lower cAMP changes how cells behave, affecting mood and other functions.
The decrease in cAMP leads to reduced PKA activity and altered phosphorylation of target proteins, which can modulate ion channel conductance, neurotransmitter release, and gene expression. In neurons, this can result in hyperpolarization and reduced firing, contributing to the anxiolytic and antidepressant effects of 5-HT1A receptor activation. Additionally, Gβγ subunits can directly regulate ion channels and other effectors.
Crosstalk with Other Gi/o-coupled Receptors
In simple terms: These receptors can interact with other similar receptors to fine-tune signals.
Gi/o-coupled serotonin receptors can compete with other Gi/o-coupled receptors for adenylyl cyclase signaling, as shown in SH-SY5Y cells where they reduce opioid-mediated cAMP overshoot. In atrial myocytes, 5-HT1A receptor activation mutually influences muscarinic M2 receptor signaling, demonstrating functional interactions between Gi/o-coupled receptors. Such crosstalk is important for integrating multiple neurotransmitter signals within a cell.
Key Genes Involved in GO:0001586 Gi/o-coupled serotonin receptor activity
The following genes encode receptors or proteins directly involved in Gi/o-coupled serotonin receptor activity and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HTR1A | Encodes the 5-HT1A receptor, a prototypical Gi/o-coupled serotonin receptor | Target for antidepressants and anxiolytics; key regulator of mood and behavior |
| HTR1B | Encodes the 5-HT1B receptor, which couples to Gi/o | Modulates aggression, impulsivity, and drug responses |
| HTR1D | Encodes the 5-HT1D receptor, a Gi/o-coupled autoreceptor | Involved in migraine pathophysiology and vascular tone |
| HTR1E | Encodes the 5-HT1E receptor, Gi/o-coupled | Less studied; potential role in cognition |
| HTR1F | Encodes the 5-HT1F receptor, Gi/o-coupled | Target for migraine treatment |
| GNAI1 | Encodes Gαi1 subunit, mediates inhibition of adenylate cyclase | Central to Gi/o signaling; knockout models available |
| GNAI2 | Encodes Gαi2 subunit | Involved in neuronal signaling and behavior |
| GNAI3 | Encodes Gαi3 subunit | Modulates cAMP in various tissues |
| GNAO1 | Encodes Gαo subunit, abundant in neurons | Mutations linked to neurological disorders |
| ADCY1 | Encodes adenylate cyclase 1, inhibited by Gαi/o | Key effector in cAMP regulation |
| ADCY5 | Encodes adenylate cyclase 5 | Modulates cAMP in striatum and other regions |
| ADCY6 | Encodes adenylate cyclase 6 | Involved in cardiac and neuronal cAMP signaling |
| GPR88 | Orphan Gi/o-coupled receptor; interacts with serotonin system | Knockout mice show motor deficits and anxiety |
| HTR2A | Encodes 5-HT2A receptor, which can form heteromers with Gi/o-coupled receptors | Implicated in schizophrenia and antipsychotic action |
| OPRM1 | Encodes mu-opioid receptor, a Gi/o-coupled receptor | Crosstalk with serotonin receptors affects cAMP overshoot |
| CHRM2 | Encodes muscarinic M2 receptor, a Gi/o-coupled receptor | Interacts with 5-HT1A in atrial myocytes |
| OPN1SW | Encodes short-wave sensitive cone opsin, used to control Gi/o signaling | Optogenetic tool for anxiety circuitry |
| OPN1MW | Encodes medium-wave sensitive cone opsin | Optogenetic control of Gi/o signaling |
How Is Gi/o-coupled serotonin receptor activity Regulated?
The activity of Gi/o-coupled serotonin receptors is regulated at multiple levels. Receptor desensitization and internalization occur via phosphorylation by G protein-coupled receptor kinases (GRKs) and arrestin recruitment, which dampens signaling. Long-term antidepressant treatments can lead to tonic activation of forebrain 5-HT1A receptors, indicating adaptive regulation. Additionally, the expression and function of these receptors can be influenced by heteromerization with other receptors, such as the mGlu2-5-HT2A complex, which alters signaling properties. The availability of serotonin itself is controlled by synthesis, reuptake, and degradation, indirectly affecting receptor activity.
Gi/o-coupled serotonin receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HTR1A | Depression, anxiety | Knockout mice, point-mutation knock-in mice, overexpression in raphe neurons |
| HTR2A | Schizophrenia | Heteromeric receptor complex models, knockout mice |
| GPR88 | Motor deficit, anxiety | Knockout mice, overexpression |
| OPRM1 | Opioid tolerance, pain | cAMP overshoot assays in SH-SY5Y cells, knockout mice |
| CHRM2 | Cardiac arrhythmia | Atrial myocyte models, knockout rats |
Depression and Anxiety Disorders
Gi/o-coupled serotonin receptors, particularly 5-HT1A, are critically involved in the pathophysiology and treatment of depression and anxiety. Long-term antidepressant treatments result in tonic activation of forebrain 5-HT1A receptors, which correlates with therapeutic efficacy. Genetic and pharmacological studies have shown that 5-HT1A receptor signaling modulates anxiety-like behavior, and its dysfunction is associated with mood disorders. Targeting this receptor remains a major strategy for antidepressant drug development.
Schizophrenia
Alterations in serotonergic signaling, including Gi/o-coupled receptors, have been implicated in schizophrenia. The formation of heteromeric complexes between mGlu2 and 5-HT2A receptors, which can influence Gi/o signaling, has been proposed to contribute to schizophrenia pathophysiology and may affect antipsychotic drug response. Additionally, 5-HT1A receptor agonists are being explored as adjunctive treatments for schizophrenia.
Cardiovascular and Autonomic Disorders
Gi/o-coupled serotonin receptors are expressed in the heart and blood vessels, where they modulate cardiac function. In rat atrial myocytes, 5-HT1A receptor activation mutually influences muscarinic M2 receptor signaling, suggesting a role in autonomic regulation of heart rate. Dysregulation of these receptors could contribute to arrhythmias or other cardiovascular conditions, although further research is needed.
Pain and Opioid Use Disorders
Gi/o-coupled serotonin receptors can modulate opioid signaling. In SH-SY5Y cells, activation of Gi/o-coupled receptors reduces opioid-mediated cAMP overshoot, a phenomenon linked to opioid tolerance and withdrawal. This crosstalk suggests that serotonin receptors may influence pain perception and the development of opioid use disorders, making them potential targets for intervention.
From Gi/o-coupled serotonin receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of 5-HT1A receptor affect anxiety-like behavior? | HTR1A knockout mouse |
| How does a point mutation in HTR1A affect Gi/o coupling? | CRISPR knock-in of point mutation in HTR1A |
| Can overexpression of 5-HT1A rescue depression-like phenotypes? | Viral overexpression of HTR1A in raphe nucleus |
| What is the role of Gαo in serotonin signaling? | GNAO1 knockout or conditional knockout mice |
| How does GPR88 modulate Gi/o signaling in anxiety? | GPR88 knockout mice |
| Can optogenetic control of Gi/o signaling mimic serotonin effects? | Cone opsin knock-in mice for Gi/o modulation |
How to Study the Gi/o-coupled serotonin receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| cAMP luminescence assay | Intracellular cAMP levels | Assessing Gi/o-mediated inhibition of adenylate cyclase |
| Radioligand binding | Receptor affinity and density | Characterizing mutant receptors |
| FRET-based cAMP sensor | Real-time cAMP dynamics | Live-cell imaging of Gi/o signaling |
| Electrophysiology | Neuronal excitability and synaptic transmission | Studying effects of 5-HT1A activation |
| Behavioral tests (e.g., forced swim) | Depression-like and anxiety-like behaviors | Evaluating knockout or transgenic mice |
| Optogenetics with cone opsins | Gi/o signaling control in vivo | Mapping anxiety circuits |
| Immunohistochemistry | Receptor localization and expression | Validating knockout or knock-in models |
| RNA-seq | Transcriptomic changes | Identifying downstream targets of Gi/o signaling |
cAMP Assays
Measuring intracellular cAMP levels is a direct way to assess Gi/o-coupled serotonin receptor activity. For example, in SH-SY5Y cells, forskolin-stimulated cAMP production can be inhibited by receptor activation, and this readout is used to study receptor crosstalk. Such assays are typically performed with luminescent or fluorescent cAMP biosensors or ELISA-based kits.
Receptor Binding Assays
Radioligand binding assays using tritiated serotonin agonists or antagonists can quantify receptor affinity and density. These methods are useful for characterizing point mutations that alter ligand binding or G protein coupling. They are often combined with functional assays to correlate binding with activity.
Genetically Encoded Indicators and Imaging
Genetically encoded calcium or cAMP indicators can be used to monitor Gi/o-coupled receptor signaling in live cells or neurons. For instance, optogenetic tools like cone opsins have been employed to control Gi/o signaling in anxiety circuits, with readouts such as electrophysiology or behavioral tracking. Imaging techniques such as FRET-based sensors allow real-time visualization of cAMP changes.
Behavioral Assays in Animal Models
To link Gi/o-coupled serotonin receptor activity to behavior, rodent models are subjected to tests such as the forced swim test, elevated plus maze, or open field. These assays have been used to demonstrate the anxiolytic and antidepressant-like effects of 5-HT1A receptor activation. Knockout and transgenic lines are essential for causal inference.
How CRISPR Can Be Used to Study GO:0001586 Gi/o-coupled serotonin receptor activity
Knockout
CRISPR knockout of genes encoding Gi/o-coupled serotonin receptors (e.g., HTR1A) or their G protein subunits (e.g., GNAI1) allows researchers to abolish specific signaling components and assess their contribution to cellular and behavioral phenotypes. For example, HTR1A knockout mice display altered anxiety-like behavior and antidepressant responses. Knockout models are essential for establishing causality in serotonin signaling pathways.
Point Mutation
CRISPR-mediated point mutations can mimic naturally occurring or designed amino acid substitutions in receptors or G proteins to dissect structure-function relationships. For instance, mutating residues in the serotonin binding pocket or G protein interface can reveal their roles in Gi/o coupling and downstream cAMP inhibition. Such models are valuable for understanding receptor activation mechanisms and drug specificity.
Knock-in
Knock-in of reporter genes, tags, or humanized sequences enables precise tracking and manipulation of Gi/o-coupled serotonin receptors. For example, knocking in a fluorescent tag on HTR1A allows visualization of receptor trafficking and localization in vivo. Knock-in of disease-associated mutations can model human conditions and test targeted therapies.
Overexpression
Overexpression of Gi/o-coupled serotonin receptors or their downstream effectors using CRISPR activation or viral vectors can enhance signaling and probe gain-of-function effects. Overexpressing 5-HT1A in specific brain regions has been used to study its role in mood regulation and to test potential therapeutic interventions. Overexpression models complement knockout studies by providing a bidirectional approach to understanding receptor function.
How EDITGENE Supports Gi/o-coupled serotonin receptor activity Research
Researchers studying Gi/o-coupled serotonin receptor activity-related genes often need to determine whether a candidate gene is causally involved in signaling, behavior, or disease. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types or organisms. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such investigations.
Contact EDITGENE today to design your custom CRISPR model for Gi/o-coupled serotonin receptor activity research.
Frequently Asked Questions About Gi/o-coupled serotonin receptor activity
What is GO:0001586?
GO:0001586 is the Gene Ontology term for Gi/o-coupled serotonin receptor activity, a molecular function where serotonin binding activates Gi/o proteins to inhibit adenylate cyclase and reduce cAMP levels.
What genes are involved in Gi/o-coupled serotonin receptor activity?
Key genes include HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, and G protein subunits such as GNAI1, GNAI2, GNAI3, and GNAO1.
How does Gi/o-coupled serotonin receptor signaling work?
Serotonin binds to the receptor, which activates Gi/o proteins; the Gαi/o subunit then inhibits adenylate cyclase, decreasing cAMP and downstream PKA activity.
What diseases are associated with Gi/o-coupled serotonin receptors?
They are implicated in depression, anxiety, schizophrenia, cardiovascular disorders, and pain/opioid tolerance.
What is the role of 5-HT1A receptor in depression?
5-HT1A is a Gi/o-coupled serotonin receptor that mediates antidepressant effects; long-term antidepressant treatment leads to tonic activation of forebrain 5-HT1A receptors.
How can I study Gi/o-coupled serotonin receptor activity in the lab?
Common methods include cAMP assays, radioligand binding, FRET sensors, electrophysiology, and behavioral tests in knockout or transgenic animals.
What CRISPR models are available for Gi/o-coupled serotonin receptors?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like HTR1A, GNAI1, and ADCY1 to study signaling and behavior.
Can Gi/o-coupled serotonin receptors interact with other receptors?
Yes, they can form heteromers or compete for signaling with other Gi/o-coupled receptors, such as muscarinic M2 or opioid receptors.
What is the downstream effect of Gi/o-coupled serotonin receptor activation?
The primary effect is inhibition of adenylate cyclase, leading to decreased cAMP levels and reduced PKA activity, which modulates ion channels and neurotransmitter release.
How does EDITGENE support Gi/o-coupled serotonin receptor research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to study these receptors and their signaling pathways.
Conclusion
Gi/o-coupled serotonin receptor activity (GO:0001586) is a fundamental molecular function that mediates serotonin's inhibitory effects on cAMP signaling, with critical roles in mood, anxiety, and cardiovascular function. Understanding its mechanisms through CRISPR-based models and functional assays can reveal new therapeutic targets for psychiatric and neurological disorders. EDITGENE offers comprehensive services to support such research, from gene editing to bioinformatics.
References
- 1. Albert PR et al.. 2019. The 5-HT1A receptor: Signaling to behavior.. Biochimie 161:34-45 PMID: 31079617
- 2. Levitt ES et al.. 2011. Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.. Mol Pharmacol 79(3):461-71 PMID: 21098043
- 3. Vanhoose AM et al.. 2004. Regulation of cAMP levels in area CA1 of hippocampus by Gi/o-coupled receptors is stimulus dependent in mice.. Neurosci Lett 370(1):80-3 PMID: 15489022
- 4. Bösche LI et al.. 2003. Transfection with 5-HT1A receptor gene and antisense directed against muscarinic M2 receptors reveal a mutual influence between Gi/o-coupled receptors in rat atrial myocytes.. J Mol Cell Cardiol 35(1):99-107 PMID: 12623304
- 5. Moreno JL et al.. 2016. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.. Sci Signal 9(410):ra5 PMID: 26758213
- 6. Masseck OA et al.. 2014. Vertebrate cone opsins enable sustained and highly sensitive rapid control of Gi/o signaling in anxiety circuitry.. Neuron 81(6):1263-1273 PMID: 24656249
- 7. Meirsman AC et al.. 2016. Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist.. Biol Psychiatry 79(11):917-27 PMID: 26188600
- 8. Haddjeri N et al.. 1998. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors.. J Neurosci 18(23):10150-6 PMID: 9822768
